OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: The J. David Gladstone Institutes

4 Projects | 4 Researchers | $577,700 Invested

2017

The J. David Gladstone Institutes

Steven Finkbeiner, MD, PhD

Novel human FTLD neuron and microglia cell models for drug discovery

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: TDP-43
  • Status: Closed

2011

The J. David Gladstone Institutes

Robert Mahley, MD, PhD

Identification of Small Molecules That Can Prevent Mitochondrial Dysfunction Associated with the Generation of Apolipoprotein E Fragments in Neurons

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2010

The J. David Gladstone Institutes

Lennart Mucke, MD

Genome Wide RNAi Screen to Identify Inhibitors of Tau Expression

  • Funding Amount: $177,700
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2010

The J. David Gladstone Institutes

Li Gan, PhD

Development of Allosteric Activators of Cathepsin B to Treat Alzheimer's Disease

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed